Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Asset Utilization Ratio: 2022-2024

Historic Asset Utilization Ratio for Kiniksa Pharmaceuticals International (KNSA) over the last 3 years, with Dec 2024 value amounting to 0.76.

  • Kiniksa Pharmaceuticals International's Asset Utilization Ratio rose 24.43% to 0.87 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.87, marking a year-over-year increase of 24.43%. This contributed to the annual value of 0.76 for FY2024, which is 39.50% up from last year.
  • Per Kiniksa Pharmaceuticals International's latest filing, its Asset Utilization Ratio stood at 0.76 for FY2024, which was up 39.50% from 0.55 recorded in FY2023.
  • Over the past 5 years, Kiniksa Pharmaceuticals International's Asset Utilization Ratio peaked at 0.76 during FY2024, and registered a low of 0.03 during FY2022.
  • Its 3-year average for Asset Utilization Ratio is 0.45, with a median of 0.55 in 2023.
  • Data for Kiniksa Pharmaceuticals International's Asset Utilization Ratio shows a peak YoY skyrocketed of 1,798.05% (in 2023) over the last 5 years.
  • Kiniksa Pharmaceuticals International's Asset Utilization Ratio (Yearly) stood at 0.03 in 2022, then surged by 1,798.05% to 0.55 in 2023, then spiked by 39.50% to 0.76 in 2024.